IGF2BP2-mediated m6A modification of IGF1R mRNA promotes neuronal senescence and cognitive decline in Alzheimer’s disease
Brain Research · 2026-01 · 1871 · 150067
DOI: 10.1016/j.brainres.2025.150067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2026-01. Verfasst von Shan Hui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410011, China. Hauptthemen laut MEDLINE: Neurons, Alzheimer Disease, Cognitive Dysfunction, RNA-Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation.
Themen: Demenz
Abstract (Originalsprache)
BACKGROUND: Alzheimer's disease (AD) is characterized by cognitive decline and neuronal loss, with cellular senescence emerging as a key driver. The insulin-like growth factor-1 receptor (IGF1R) pathway is implicated in aging and AD pathology. IGF2 mRNA binding protein 2 (IGF2BP2) can stabilize IGF1R mRNA, but its role in AD-associated neuronal senescence remains unclear. METHODS: We established AD mouse models and H2O2-induced senescent neuronal cell models to explore the impact of IGF2BP2 in neuronal senescence and cognitive deficits. RNA pull-down assays, methylated RNA immunoprecipitation (MeRIP)-qPCR, and behavioral tests were used to elucidate the molecular mechanisms and therapeutic potential of targeting IGF2BP2. RESULTS: IGF2BP2 was significantly up-regulated in the hippocampal neurons of AD mice. This upregulation correlated with increased β-amyloid (Aβ) deposition, neuronal damage, and cognitive impairments. In vitro, IGF2BP2 knockdown in H2O2-induced senescent neurons reduced IGF1R expression and alleviated neuronal senescence, as evidenced by decreased senescence-associated secretory phenotype factors and improved cell viability. Mechanistically, IGF2BP2 stabilized IGF1R mRNA through m6A modification, enhancing its expression. Knockdown of IGF2BP2 decreased IGF1R mRNA stability and expression, thereby mitigating neuronal senescence. In AD mice, IGF2BP2 knockdown improved cognitive function, reduced Aβ deposition, and delayed neuronal senescence. CONCLUSION: IGF2BP2 contributes to neuronal senescence and cognitive deficits in AD by regulating IGF1R expression through m6A modification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410011, China.
- Department of Joint and Sports Medicine, The Affiliated Zhuzhou Hospital Xiangya Medical College, Central South University, Zhuzhou, Hunan 412007, China.
- School of Public Health, Changsha Medical University, Changsha, Hunan 410203, China.
- School of Information Engineering, Changsha Medical University, Changsha, Hunan 410219, China.
- Department of Geriatrics, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410011, China. Electronic address: 597148530@qq.com.
- Department of Geriatrics, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410011, China. Electronic address: llh0020@163.com.
Förderung
- Hunan Provincial Natural Science Foundation
Zitieren
APA
Hui, S., Long, Y., Zhu, L., Shi, W., Zheng, Q., & Liang, L. (2026). IGF2BP2-mediated m6A modification of IGF1R mRNA promotes neuronal senescence and cognitive decline in Alzheimer’s disease. Brain Research, 1871, 150067. https://doi.org/10.1016/j.brainres.2025.150067
Vancouver
Hui S, Long Y, Zhu L, Shi W, Zheng Q, Liang L. IGF2BP2-mediated m6A modification of IGF1R mRNA promotes neuronal senescence and cognitive decline in Alzheimer’s disease. Brain Research. 2026;1871:150067. doi:10.1016/j.brainres.2025.150067
BibTeX
@article{Hui2026,
author = {Hui, Shan and Long, Yi and Zhu, Lemei and Shi, Wei and Zheng, Qing and Liang, Lihui},
title = {IGF2BP2-mediated m6A modification of IGF1R mRNA promotes neuronal senescence and cognitive decline in Alzheimer’s disease},
journal = {Brain Research},
year = {2026},
volume = {1871},
pages = {150067},
doi = {10.1016/j.brainres.2025.150067}
}
EUVIMED